Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis

J Clin Neurosci. 2012 Sep;19(9):1326-7. doi: 10.1016/j.jocn.2011.11.029. Epub 2012 Jun 20.

Abstract

Cerebral venous thrombosis (CVT) has been associated with thrombophilic defects. We performed a study to evaluate the role of three single nucleotide polymorphisms (SNP), factor V Leiden G1691A (FVL), prothrombin gene mutation G20210A (FII-G20210A) and methylenotetrahydrofolate reductase variant C677T (MTHFR-C677T), as risk factors for CVT in Tunisian patients. A single center case-control study (26 patients with CVT and 197 controls) was performed. Genomic DNA was tested for the three SNP. The principle finding was the association between FVL and CVT (p<0.001, Odds ratio=6.1, 95% confidence interval=2.3-16.5). However, neither the FII-G20210 (p=0.536) nor the homozygous MTHFR-C677T genotype (p=0.325) variant contributed to the risk of CVT in these Tunisian patients.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Factor V / genetics*
  • Female
  • Genotype
  • Humans
  • Intracranial Thrombosis / genetics*
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Middle Aged
  • Polymorphism, Genetic / genetics
  • Polymorphism, Single Nucleotide / genetics
  • Prothrombin / genetics*
  • Risk Factors
  • Tunisia
  • Venous Thrombosis / genetics*
  • Young Adult

Substances

  • factor V Leiden
  • Factor V
  • Prothrombin
  • Methylenetetrahydrofolate Reductase (NADPH2)